Skip to main content
Caplight Logo









Unravel Biosciences

Unravel Biosciences

Private
Medford, MassachusettsHealthcare & Life Scienceshttps://www.unravel.bio/

Last Round

Seed Round

Aug 24, 2026

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Unravel Biosciences is a biotechnology company that provides an artificial intelligence-driven systems biology platform designed to discover and clinically validate therapeutic targets for complex diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

AI drug discoveryin-silico drug discoveryrare disease therapeuticsdrug target discoveryprecision medicinedrug discovery platformrare neurological disorderscomputational biologydigital twin for biologydrug repurposingpatient stratificationorphan drug developmentRNA data analysistranscriptomicsin-vivo screeningtadpole models

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Unravel Biosciences Comparables

Compare Unravel Biosciences with similar companies based on industry and business-model similarity.

Unravel Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Transcripta Bio
85%
Scripta Therapeutics
80%
Aitia
79%

Unravel Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundAug 24, 2026
SeedJun 14, 2022

Key People

Founding team and executive leadership

Richard Novak

Co-founder and CEO

Founding Team

Unravel Biosciences Investors

Notable investors and investment history

Unravel Biosciences investors
InvestorRounds
RTK GroupSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 24, 2026

    $4.1M raised in Seed Round.

  • Jul 25, 2026

    Monthly visitors grew 57% MoM, reaching 3.3K.

Unravel Biosciences Filings

Explore SEC and related filing metadata, where available.

Unravel Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Unravel Biosciences's valuation, stock price, and market status.

Is Unravel Biosciences a public or private company?

Unravel Biosciences is a private company.

What is the current stock price of Unravel Biosciences?

Unravel Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Unravel Biosciences worth (valuation)?

Valuation information for Unravel Biosciences is not publicly available.

Can I buy Unravel Biosciences stock?

Unravel Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Unravel Biosciences's last funding round?

Unravel Biosciences's most recent funding round was Seed on June 14, 2022.

Who are the main investors in Unravel Biosciences?

Key investors in Unravel Biosciences include RTK Group.

Will Unravel Biosciences IPO soon?

No public IPO plans have been announced for Unravel Biosciences.

How can I track Unravel Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Unravel Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMedford, Massachusetts
Employee Range14
Year Founded2021
Last FundingAug 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?